Propofol does not induce pulmonary dysfunction in stressed endotoxic pigs receiving intralipid

Critical Care Medicine

Volumn 31, Issue 7, 2003, Pages 2029-2033

  Ziser, Avishai ^a   Strickland, Robert A ^b   Murray, Michael J ^c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Acute lung injury; Diisopropyl phenol; Hypoxia; Lipid emulsions; Pulmonary vascular resistance; Sedation in the intensive care unit; Thromboxane A2

Indexed keywords

ADRENALIN; ATROPINE; BUPIVACAINE; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HALOTHANE; INTRALIPID; KETAMINE; PROPOFOL; THROMBOXANE B2;

ANIMAL MODEL; ARTICLE; BLOOD GAS ANALYSIS; BOLUS INJECTION; CENTRAL VENOUS PRESSURE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORE TEMPERATURE; DOSE RESPONSE; DRUG EFFECT; ENDOTOXEMIA; HEART OUTPUT; HEART RATE; HEMODYNAMIC PARAMETERS; INTENSIVE CARE UNIT; LUNG ARTERY PRESSURE; LUNG INJURY; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEDATION; SWINE; TREATMENT OUTCOME;

EID: 0041866157     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000070445.76287.6E     Document Type: Article

References (27)

1. Merriman HM: The techniques used to sedate ventilated patients. A survey of methods used in 34 ICUs in Great Britain. Intensive Care Med 1981; 7:217-224
2. Aitkenhead AR, Pepperman ML, Willatts SM, et al: Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989; 2:704-709
3. Amos RJ, Amess JAL, Hinds CJ, et al: Incidence and pathogenesis of acute megaloblastic bone-marrow change in patients receiving intensive care. Lancet 1992; 2:825-838
4. Kenyon CJ, McNeil LM, Fraser R: Comparison of the effects of etomidate, thiopentone, and propofol on cortisol synthesis. Br J Anaesth 1985; 57:509-511
5. Parke TJ, Stevens JE, Rice AS, et al: Metabolic acidosis and fatal myocardial failure after propofol infusion in children: Five case reports. BMJ 1992; 305:613-616
6. Newman LH, McDonald JC, Wallace PG, et al: Propofol infusion for sedation in intensive care. Anaesthesia 1987; 42:929-937
7. Au J, Walker WS, Scott DH: Withdrawal syndrome after propofol infusion. Anaesthesia 1990; 45:741-742
8. Valente JF, Anderson GL, Branson RD, et al: Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med 1994; 22:710-712
9. Arduino MJ, Bland LA, McAllister SK, et al: Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infect Control Hosp Epidemiol 1991; 12:535-539
10. Abbott WC, Grakauskas AM, Bistrian BR, et al: Metabolic and respiratory effects of continuous and discontinuous lipid infusions. Arch Surg 1984; 119:1367-1371
11. Suchner U, Katz DP, Fürst P, et al: Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis. Crit Care Med 2001; 29:1569-1574
12. 2. Intensive Care Med 2002; 28:122-129
13. Nuttall GA, Murray MJ, Bowie EJW: Protamine-heparin-induced pulmonary hypertension in pigs: Effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Anesthesiology 1991; 74:138-145
14. Sprecher H: An update on the pathways of polyunsaturated fatty acid metabolism. Curr Opin Clin Nutr Metab Care 1999; 2:135-138
15. Schwartz J: Role of polyunsaturated fatty acids in lung. Am J Clin Nutr 2000; 71:393S-396S
16. Massey NJ, Sherry KM, Oldroyd S, et al: Pharmacokinetics of an infusion of propofol during cardiac surgery. Br J Anaesth 1990; 65:475-479
17. Murray MJ, Svingen BA, Holman RT, et al: Effects of a fish oil diet on pigs' cardiopulmonary response to bacteremia. JPEN J Parenter Enteral Nutr 1991; 15:152-158
18. Murray MJ, Svingen BA, Yaksh TL, et al: Effects of endotoxin on pigs prefed ω-3 vs. ω-6 fatty acid-enriched diets. Am J Physiol 1993; 265:E920-E927
19. Matsuda T, Eccleston CA, Rubinstein I, et al: Antioxidants attenuate endotoxin-induced microvascular leakage of macromolecules in vivo. J Appl Physiol 1991; 70:1483-1489
20. D'Orio V, Fatemi M, Marnette JM, et al: Analysis of endotoxin effects on pulmonary circulation in terms of pressure-flow characteristics. Circ Shock 1993; 39:285-292
21. Basu S, Mutschler DK, Larsson AO, et al: Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001; 50:341-348
22. Jacobi J, Fraser GL, Coursin DB, et al: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119-141
23. Barrington KJ, Chan G, Van Aerde JE: Intravenous lipid composition affects hypoxic pulmonary vasoconstriction in the newborn piglet. Can J Physiol Pharmacol 2001; 79:594-600
24. Uezono S, Clarke WR: The effect of propofol on normal and increased pulmonary vascular resistance in isolated perfused rabbit lung. Anesth Analg 1995; 80:577-582
25. Duke T, Egger CM, Ferguson JG, et al: Cardiopulmonary effects of propofol infusion in llamas. Am J Vet Res 1997; 58:153-156
26. Rich GF, Roos CM, Anderson SM, et al: Direct effects of intravenous anesthetics on pulmonary vascular resistance in the isolated rat lung. Anesth Anal 1994; 78:961-966
27. Hammaren E, Hynynen M: Haemodynamic effects of propofol infusion for sedation after coronary artery surgery. Br J Anaesth 1995; 75:47-50